Vanguard Capital Management
RCKT icon

Vanguard Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Vanguard Capital Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9M Buy
3,784,387
+8,651
+0.2% +$28.8K ﹤0.01% 2684
2026
Q1 		$13.5M Buy
+3,775,736
New +$15M ﹤0.01% 2564

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management's RCKT Position: Q2 2026 in Review

Vanguard Capital Management increased its Rocket Pharmaceuticals (RCKT) stake by 0.23% in Q2 2026, buying an estimated $28.8K and bringing the position to 3,784,387 shares worth $12.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2684.

Vanguard Capital Management first reported a position in RCKT in Q1 2026 and has held it in 2 quarters since. The position peaked at $13.5M in Q1 2026. 177 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Vanguard Capital Management held 3,784,387 shares of Rocket Pharmaceuticals worth $12.9M as of Q2 2026.
  • Vanguard Capital Management bought 8,651 Rocket Pharmaceuticals shares in Q2 2026, an estimated $28.8K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2684 holding.
  • Vanguard Capital Management first reported a position in Rocket Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Rocket Pharmaceuticals position peaked at $13.5M in Q1 2026.
  • 177 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.